Scientists have developed a maternal blood test that detects thousands of genetic conditions in foetuses, offering a non-invasive alternative to procedures like amniocentesis.
Researchers developed NIFS, a maternal blood test detecting thousands of genetic conditions with 95-99% accuracy. It eliminates invasive screening and signals the market shift toward advanced computing-driven diagnostics—opportunities for healthcare tech infrastructure.
The breakthrough could significantly reduce the need for invasive screening methods
Jun 13, 2026
02:15 pm
What's the storyScientists have developed a new maternal blood test capable of detecting thousands of serious genetic conditions in a developing fetus.
The breakthrough could significantly reduce the need for invasive screening methods during pregnancy.
Blood test can find thousands of genetic conditions in pregnancy, say scientists
Large-scale population studies needed to reduce risks from newborn genome screening, investigators conclude
The test that could save millions of women from chemotherapy | The Jerusalem Post
District hospitals can bring specialised prenatal diagnosis closer to rural families, study finds
Technique that examines fragments of foetal DNA in mother’s bloodstream could limit need for invasive screening, according to…
A new rapid blood test for newborns could potentially detect genetic mutations linked to thousands of rare diseases all at once,…
Studies show these can help detect pre-eclampsia and predict preterm births
Scientists have created a wearable piece of technology that can continuously monitor an unborn baby and potentially spot…
Discover how liquid biopsy can enhance early detection of pregnancy risks and improve maternal and fetal health outcomes.
The device aims to reduce false alarms, cut unnecessary hospital visits, and expand access to prenatal care in low-resource…
